title: Donor lymphocyte infusions for the treatment of minimal residual disease in acute leukemia.
authors.forename: Alida
authors.initials: A
authors.lastname: Dominietto
authors.forename: Sarah
authors.initials: S
authors.lastname: Pozzi
authors.forename: Maurizio
authors.initials: M
authors.lastname: Miglino
authors.forename: Flavio
authors.initials: F
authors.lastname: Albarracin
authors.forename: Giovanna
authors.initials: G
authors.lastname: Piaggio
authors.forename: Francesca
authors.initials: F
authors.lastname: Bertolotti
authors.forename: Raffaella
authors.initials: R
authors.lastname: Grasso
authors.forename: Simona
authors.initials: S
authors.lastname: Zupo
authors.forename: Anna Maria
authors.initials: AM
authors.lastname: Raiola
authors.forename: Marco
authors.initials: M
authors.lastname: Gobbi
authors.forename: Francesco
authors.initials: F
authors.lastname: Frassoni
authors.forename: Andrea
authors.initials: A
authors.lastname: Bacigalupo
mesh_terms: D000208:Acute Disease; D006086:Graft vs Host Disease / Q000378:metabolism; D006801:Humans; D016219:Immunotherapy, Adoptive; D007938:Leukemia / Q000628:therapy*; D017710:Lymphocyte Transfusion / Q000379:methods*; D018365:Neoplasm, Residual; D011237:Predictive Value of Tests; D012008:Recurrence; D012074:Remission Induction; D012306:Risk; D033581:Stem Cell Transplantation / Q000379:methods*; D013997:Time Factors; D014184:Transplantation, Homologous